|
|
| CrossRef Text and Data Mining | |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
| Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11 | |
| Jong Seo Yoon, Kyu Jung Park, Young Bae Sohn, Hae Sang Lee, Jin Soon Hwang | |
|
Ann Pediatr Endocrinol Metab. 2018;23(3):154-157. Published online September 28, 2018 DOI: https://doi.org/10.6065/apem.2018.23.3.154 |
|
|
Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11 Annals of Pediatric Endocrinology & Metabolism. 2018;23(3):154-157  Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation Diabetes Research and Clinical Practice. 2015;108(1):e18-e20 Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation Pediatric Diabetes. 2009;11(4):286-288 Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: A case report Diabetes Research and Clinical Practice. 2013;100(1):e1-e2 Mother and daughter carrying the same KCNJ11 mutation but with a different response to switching from insulin to sulfonylurea Diabetes Research and Clinical Practice. 2011;94(2):e50-e52 Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation Diabetes Research and Clinical Practice. 2011;91(1):e1-e3 Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11 Pediatric Diabetes. 2007;8(4):235-238 Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide Pediatric Diabetes. 2008;9(3pt1):236-239 Efficacy and Safety of Sulfonylurea Use in Permanent Neonatal Diabetes Due to KCNJ11 Gene Mutations: 34-Month Median Follow-Up Diabetes Technology & Therapeutics. 2010;12(5):387-391 Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM Pediatric Diabetes. 2009;11(3):203-207 |
